+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neoantigen"

From
From
From
TCR Therapy Market Report 2025 - Product Thumbnail Image

TCR Therapy Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Intratumoral Cancer Therapies Market Report 2025 - Product Thumbnail Image

Intratumoral Cancer Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neoantigen Targeted Therapies Market Report 2025 - Product Thumbnail Image

Neoantigen Targeted Therapies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Innovation Waves in Immuno-oncology Therapy Development - Product Thumbnail Image

Innovation Waves in Immuno-oncology Therapy Development

  • Report
  • February 2024
  • 75 Pages
  • Global
From
Drugs for Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Drugs for Immunotherapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
Gene Therapy-Competitive landscape, 2023 - Product Thumbnail Image

Gene Therapy-Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
mRNA Cancer Therapies Patent Landscape 2022 - Product Thumbnail Image

mRNA Cancer Therapies Patent Landscape 2022

  • Report
  • September 2022
  • Global
From
From
Drug Delivery in Cancer - Technologies, Markets & Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets & Companies

  • Report
  • November 2021
  • 747 Pages
  • Global
From
Loading Indicator

The Neoantigen market is a subset of the Genomics market that focuses on the identification and development of neoantigens for use in cancer immunotherapy. Neoantigens are proteins that are produced by tumor cells and are recognized by the immune system as foreign, triggering an immune response. By targeting these neoantigens, cancer immunotherapy can be used to treat cancer. Companies in the Neoantigen market are focused on developing technologies to identify and develop neoantigens for use in cancer immunotherapy. Companies in the Neoantigen market include Adaptive Biotechnologies, I-Mab, Neoantigen Therapeutics, NeoVax, and OncoImmune. Show Less Read more